美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾格里房產

73.28

-0.4050-0.55%

成交量：14.54萬

成交額：1,065.50萬

市值：80.95億

市盈率：43.56

高：73.51

開：73.41

低：72.97

收：73.68

資料載入中...

總覽公司新聞公告

復星醫藥：控股子公司獲美國FDA藥品臨牀試驗批准

Macrogenics, Inc.盤中異動早盤快速下挫5.03%

輝瑞2025H1：ADC產品銷售收入15億美元，還有130億美元BD彈藥

總規模470億港幣，晶泰科技創AI藥物發現合作訂單新紀錄

競逐創新藥賽道，跨國藥企中國 “買買買” 熱潮繼續

破局HER2低表達困境，ADC只是開始

港股異動 | 樂普生物-B(02157.HK)再漲超6% 自研ADC藥物MRG004A啓動III期胰腺癌臨牀

藥明合聯無錫基地DP3車間成功完成GMP放行，偶聯製劑產能擴張再上新台階

百利天恆：BMS啓動EGFR/HER3 ADC第二項全球2/3期臨牀

上海吸納生物醫藥等企業加入“探索者計劃”；邁威生物董事長被罰

21世纪经济报道

Macrogenics, Inc.盤中異動大幅上漲5.06%報1.66美元

康寧傑瑞JSKN022新藥臨牀試驗申請獲CDE受理

艾伯維2025H1：自免雙子星116億美元，FRα ADC增長76%

Agree Realty Corp 報告截至 6 月 30 日的季度業績 - 盈利摘要

Macrogenics, Inc.盤中異動股價大漲5.19%

康寧傑瑞：HER2雙抗ADC藥物獲美國FDA孤兒藥資格認定

生物药大时代

Macrogenics, Inc.盤中異動股價大跌5.09%報1.59美元

ADC崛起背後的百億美元水漂

Macrogenics, Inc.盤中異動早盤急速下挫5.06%

乳腺癌新輔助治療阿斯利康(AZN.US)/第一三共HER2 ADC新適應症擬納入優先審評

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADC/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房產","latestPrice":73.275,"timestamp":1754580930817,"preClose":73.68,"halted":0,"volume":145406,"delay":0,"floatShares":108365076,"shares":110470073,"eps":1.682184,"marketStatus":"交易中","change":-0.405,"latestTime":"08-07 11:35:40 EDT","open":73.405,"high":73.51,"low":72.97,"amount":10655035.276544,"amplitude":0.007329,"askPrice":73.3,"askSize":111,"bidPrice":73.26,"bidSize":16,"shortable":3,"etf":0,"ttmEps":1.682184,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1754596800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":73.68,"dividendRate":0.041488,"preHourTrading":{"tag":"盘前","latestPrice":74.55,"preClose":73.68,"latestTime":"09:29 EDT","volume":48,"amount":3577.42032,"timestamp":1754573341934},"postHourTrading":{"tag":"盘后","latestPrice":73.68,"preClose":73.68,"latestTime":"19:54 EDT","volume":406926,"amount":29982311.88,"timestamp":1754524477006},"volumeRatio":0.382851,"impliedVol":0.2023,"impliedVolPercentile":0.332},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":108365076,"roa":"2.31%","roe":"3.45%","lyrEps":1.793039,"volumeRatio":0.382851,"shares":110470073,"dividePrice":3.04,"high":73.51,"amplitude":0.007329,"preClose":73.68,"low":72.97,"week52Low":67.58,"pbRate":"1.48","psRate":"12.27","week52High":79.65,"institutionHeld":0.9993,"latestPrice":73.275,"committee":-0.748031,"eps":1.682184,"divideRate":0.041488,"volume":145406,"delay":0,"ttmEps":1.682184,"open":73.405,"prevYearClose":70.45,"prevWeekClose":73.73,"prevMonthClose":71.7,"prevQuarterClose":73.06,"fiveDayClose":71.7,"twentyDayClose":70.98,"sixtyDayClose":73.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557555929","title":"復星醫藥：控股子公司獲美國FDA藥品臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2557555929","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557555929?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 17:51","pubTimestamp":1754560263,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["DNA","BK0183","BK0060","BK4109","BK0096","CYB","BK0028","BK1191","UCmain","BK4023","BK0012","BK4139","ADC","BK0187","MUCmain","600196","BK0239","LU1169590202.USD","BK1593","BK4231","02696","CNHmain","BK4080","BK0188","MCNHmain","LU1169589451.USD","PD","02196","BK1161","BK0175","BK1515","BK0196"],"gpt_icon":0},{"id":"2557305683","title":"Macrogenics, Inc.盤中異動 早盤快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557305683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557305683?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 22:48","pubTimestamp":1754491719,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时48分，Macrogenics, Inc.股票出现波动，股价大幅下跌5.03%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biomx Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为598.92%、350.36%、53.16%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为45.15%、44.74%、36.81%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224839a6d6d293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224839a6d6d293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4080","MGNX","BK4231","ADC"],"gpt_icon":0},{"id":"2557624345","title":"輝瑞2025H1：ADC產品銷售收入15億美元，還有130億美元BD彈藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2557624345","media":"医药魔方","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557624345?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 08:05","pubTimestamp":1754438757,"startTime":"0","endTime":"0","summary":"8月5日，辉瑞公布2025H1业绩，上半年总营收283.67亿美元（+1%）。辉瑞在财报PPT中重点介绍了2023年获批上市用于治疗多发性骨髓瘤的CD3/BCMA双抗Elrexfio。辉瑞在2023年底以430亿美元收购Seagen所获得的产品大多在增长放量，今年上半年这些产品合计收入约为17.52亿美元，其中ADC产品合计约15.18亿美元。继三生交易后，辉瑞还有130亿美元的BD弹药，以助力实现下一个十年业务的持续增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806081005a6d54d75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806081005a6d54d75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4080","LU0456855351.SGD","LU1066053197.SGD","LU1066051498.USD","LU0868494617.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4585","IE0002270589.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0289739699.SGD","SG9999002224.SGD","BK4533","BK4534","BK4599","LU0234572021.USD","SG9999002232.USD","BK4568","ADC","BK4550","LU0058720904.USD","LU0170899867.USD","BK4581","IE00BLSP4452.SGD","LU0122379950.USD","PFE","LU1883839398.USD","LU0321505439.SGD","LU0306806265.USD","IE00BLSP4239.USD","BK4231","SG9999001176.SGD","LU1057294990.SGD","IE00BBT3K403.USD","LU0306807586.USD","IE000M9KFDE8.USD","BK4592","LU1023059063.AUD","LU1894683348.USD","LU0225284248.USD","SG9999013999.USD","BK4588","LU0225771236.USD","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD"],"gpt_icon":1},{"id":"2557317799","title":"總規模470億港幣，晶泰科技創AI藥物發現合作訂單新紀錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2557317799","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557317799?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 00:53","pubTimestamp":1754412780,"startTime":"0","endTime":"0","summary":"根据协议条款，晶泰科技与 DoveTree 就多款处于临床前阶段的大分子及小分子创新药资产达成合作，并将针对一系列 DoveTree 指定的靶点进行新药研发，DoveTree 独家享有相关药物全球范围的独家开发和商业化权利。此次合作创下人工智能+机器人新药研发领域订单规模的新纪录。这使得晶泰科技成为极其难得的战略合作伙伴，并将有机会深刻变革药物发现的合作模式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744811_ZH44811_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4231","BK4080","BK4139","BK1617","RNTX","02228","BK1141","ENTA","ADC"],"gpt_icon":0},{"id":"2557363843","title":"競逐創新藥賽道，跨國藥企中國 “買買買” 熱潮繼續","url":"https://stock-news.laohu8.com/highlight/detail?id=2557363843","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557363843?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 14:42","pubTimestamp":1754376171,"startTime":"0","endTime":"0","summary":"资产购买协议交割后，维亚臻将获得赛诺菲 1.3 亿美元的预付款，并将有资格在普乐司兰钠注射液在中国大陆的各种适应症获批后获得至多 2.65 亿美元的额外里程碑付款。这并非个例，近年来跨国药企在中国开启了 “买买买” 模式，频繁收购中国创新药企业或相关项目。不仅是辉瑞，其他跨国药企也纷纷出手。跨国药企如此热衷于在中国市场 “买买买”，背后有着深刻的原因。跨国药企在中国的 “买买买”，对中国创新药行业产生了多方面影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080514465194d09d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080514465194d09d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683348.USD","LU2417539215.USD","LU2456880835.USD","01530","LU0456855351.SGD","IE00B19Z3581.USD","ADC","BK4533","BK4568","LU2236285917.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU1883839398.USD","01801","SG9999002224.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU2462157665.USD","LU0320765992.SGD","LU0985481810.HKD","IE00BLSP4239.USD","LU0058720904.USD","LU0170899867.USD","BK4585","LU0225771236.USD","LU0306807586.USD","BK4080","SG9999013999.USD","SG9999003800.SGD","LU0234572021.USD","LU0225284248.USD","LU1057294990.SGD","BK4581","IE000M9KFDE8.USD","LU1023059063.AUD","AZN","LU1829250122.USD","PFE","BK4588","IE0002270589.USD","SG9999001176.USD","LU0889565916.HKD","BK4550","LU0321505439.SGD","LU0109394709.USD","LU0868494617.USD","LU1066051498.USD","LU1894683264.USD","BK4599","BK4534","LU0306806265.USD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2557575033","title":"破局HER2低表達困境，ADC只是開始","url":"https://stock-news.laohu8.com/highlight/detail?id=2557575033","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557575033?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 13:43","pubTimestamp":1754372627,"startTime":"0","endTime":"0","summary":"也就是说，HER2低表达人群是阳性患者的3-4倍，却长期面临无药可用的困境。一项2期研究纳入了79例HER2低表达患者，帕妥珠单抗治疗后ORR仅为2.5%。数据显示，在HER2低表达胃癌中，DS-8201的ORR可达30%以上，远超传统化疗的10%-15%。HER2低表达领域，中国药企也快速跟进。比如荣昌生物的RC48，最初其最初获批用于HER2过表达的胃癌与乳腺癌，近年开始积极延伸至HER2低表达人群。2024年6月，其用于治疗HER2低表达的晚期乳腺癌的新适应症申报获CDE受理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1754364256856005492","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"2557835616","title":"港股異動 | 樂普生物-B(02157.HK)再漲超6% 自研ADC藥物MRG004A啓動III期胰腺癌臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2557835616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557835616?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 10:35","pubTimestamp":1754361356,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4231","III","BK4134","BK4080","BK1161","02157","ADC"],"gpt_icon":0},{"id":"2557739904","title":"藥明合聯無錫基地DP3車間成功完成GMP放行，偶聯製劑產能擴張再上新台階","url":"https://stock-news.laohu8.com/highlight/detail?id=2557739904","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557739904?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 10:10","pubTimestamp":1754359800,"startTime":"0","endTime":"0","summary":"无锡2025年8月5日 /美通社/ -- 全球领先的生物偶联药物合同研究、开发和生产企业药明合联位于无锡基地的第三个偶联制剂生产车间DP3，已于7月底成功完成GMP放行，标志着公司制剂产能的进一步扩大和业务持续拓展的重要里程碑。药明合联首席执行官李锦才博士表示，\"DP3制剂车间成功完成GMP放行，既是公司发展的又一里程碑，更是迈向更高目标的新起点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744320_ZH44320_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02268","SG9999014674.SGD","ADC","BK1141","LU2488822045.USD","BK4231","BK4080"],"gpt_icon":0},{"id":"2557356516","title":"百利天恆：BMS啓動EGFR/HER3 ADC第二項全球2/3期臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356516","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557356516?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 09:48","pubTimestamp":1754358512,"startTime":"0","endTime":"0","summary":"近年来，百时美施贵宝积极扩展肿瘤领域new modality的布局，ADC领域重金引进了百利天恒的EGFR/HER3 ADC，IO领域引进了BioNTech的PD-L1/VEGF双抗，前不久又引进了OncoACP3核药。总结BL-B01D1为全球首款EGFR/HER3 ADC，也是百利天恒的核心管线，目前在国内有10项三期临床同时推进，其中5项适应症被纳入突破性治疗药物程序。百时美施贵宝则陆续启动两项全球2/3期临床，加速推进BL-B01D1的全球临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080509485597342a22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080509485597342a22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","LU1261432733.SGD","LU0456855351.SGD","LU0267386448.USD","LU2242652126.USD","LU0306806265.USD","IE00BSNM7G36.USD","BK4532","LU0868494617.USD","LU1670710661.SGD","LU2125154778.USD","LU0061475181.USD","LU1430594728.SGD","LU0306807586.USD","LU2242646821.SGD","BK4231","ADC","LU1718418525.SGD","BMS","LU0225771236.USD","LU1868837136.USD","LU0882574055.USD","LU2133065610.SGD","LU1989771016.USD","LU0096364046.USD","LU0114720955.EUR","LU0985481810.HKD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU0225284248.USD","LU0321505439.SGD","BK4080","BK4585","LU1670711040.USD","IE0002141913.USD","LU1093756168.USD","LU1868836591.USD","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0321505868.SGD","BK4581","BMY","LU1291159041.SGD","LU2125154935.USD","LU1074936037.SGD","LU1868836914.USD","IE0009355771.USD","BK4007","BK4559"],"gpt_icon":0},{"id":"2557306373","title":"上海吸納生物醫藥等企業加入“探索者計劃”；邁威生物董事長被罰","url":"https://stock-news.laohu8.com/highlight/detail?id=2557306373","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557306373?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 08:07","pubTimestamp":1754352452,"startTime":"0","endTime":"0","summary":"政策动向广东佛山：8月起到药店购布洛芬等47种治疗基孔肯雅热药物须实名登记据“佛山发布”微信公众号8月4日下午发布的消息，日前，佛山市市场监管局发布《关于疫情防控期间加强零售药店销售重点管控药品登记管理的告知书》，明确8月1日起，全市所有零售药店将严格执行销售重点管控药品登记报告制度，共涉及47种药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202508053475868152.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508053475868152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4231","BK4080","BK4017","LU1223082519.USD","LU1223082196.USD","ADC","CDE","LU1223083913.SGD"],"gpt_icon":0},{"id":"2557336418","title":"Macrogenics, Inc.盤中異動 大幅上漲5.06%報1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557336418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557336418?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 03:12","pubTimestamp":1754334742,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时12分，Macrogenics, Inc.股票出现波动，股价大幅上涨5.06%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Psyence Biomedical Ltd.、Bioxcel Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为7079.03%、1473.39%、1023.59%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为92.95%、84.21%、80.73%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805031223973384e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805031223973384e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADC","MGNX","BK4231","BK4080"],"gpt_icon":0},{"id":"2556982013","title":"康寧傑瑞JSKN022新藥臨牀試驗申請獲CDE受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2556982013","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556982013?lang=zh_tw&edition=fundamental","pubTime":"2025-08-03 20:51","pubTimestamp":1754225475,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["03347","LU1223082519.USD","LU1169590202.USD","LU1169589451.USD","BK7095","BK4080","CDE","BK4023","PD","BK4017","ADC.AU","BK7050","LU1223083913.SGD","IND.AU","ADC","CDE.AU","BK1576","BK1583","BK1141","BK4231","LU1223082196.USD","BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2556528548","title":"艾伯維2025H1：自免雙子星116億美元，FRα ADC增長76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556528548","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556528548?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 07:57","pubTimestamp":1754006232,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公布了2025H1业绩，上半年总营收287.66亿美元，同比增长7.4%。艾伯维2025H1主要产品销售额昔日“药王”Humira因专利到期和生物类似药竞争影响，自2022年开始销售额逐年下滑，今年上半年的销售额已缩水至23.01亿美元。今年上半年，艾伯维还在高频地进行各类BD交易。截至7月底，艾伯维共达成10笔交易，这一数量已接近过去几年全年的水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108061794c76a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108061794c76a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","LU1037948541.HKD","LU0170899867.USD","IE00BGHQF631.EUR","LU0158827948.USD","LU1162221912.USD","BK4224","LU1585245621.USD","SG9999011175.SGD","LU0211327993.USD","LU1003077747.HKD","LU1839511570.USD","BK4585","LU0310800379.SGD","LU1496350502.SGD","LU1244550221.USD","LU1929549753.HKD","BK4534","IE00B4R5TH58.HKD","LU2089284900.SGD","LU2237443465.HKD","LU0949170772.SGD","LU1093756168.USD","LU2237443382.USD","IE00B2B36J28.USD","BK4080","IE00B19Z3581.USD","LU2129689514.USD","LU0912757837.SGD","LU1037948897.HKD","LU2089283258.USD","LU1093756325.SGD","SG9999015986.USD","SG9999015945.SGD","LU0203345920.USD","BK4581","LU0943347566.SGD","LU2237443895.HKD","LU2129689431.USD","LU0795875169.SGD","LU2112291526.USD","ADC","ABBV","IE0009355771.USD","LU1023059063.AUD","LU0820561818.USD","LU1934455863.HKD","IE00B42XCP33.USD","FR","LU0310799852.SGD"],"gpt_icon":0},{"id":"2556859709","title":"Agree Realty Corp 報告截至 6 月 30 日的季度業績 - 盈利摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2556859709","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556859709?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 05:50","pubTimestamp":1753998655,"startTime":"0","endTime":"0","summary":"Agree Realty Corp 报告截至 6 月 30 日的季度业绩 - 盈利摘要Agree Realty Corp ADC.N公布的截至6月30日的季度调整后每股收益为43美分，低于去年同期的每股收益52美分。华尔街预期为每股收益 44 美分至 47 美分。Agree Realty Corp 公布的本季度每股收益为 43 美分。公司报告的季度净收入为 4734 万美元。Agree Realty Corp 本季度股价下跌了 0.6%，今年迄今为止上涨了 3.1%。华尔街对 Agree Realty Corp 的 12 个月目标价中位数为 82.00 美元，比其上次收盘价 71.70 美元高出约 12.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nL4T3TS2SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2556545837","title":"Macrogenics, Inc.盤中異動 股價大漲5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556545837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556545837?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 00:28","pubTimestamp":1753979328,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时28分，Macrogenics, Inc.股票出现波动，股价大幅上涨5.19%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为2.85%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Plus Therapeutics, Inc.涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为9505.52%、4995.56%、4799.53%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为297.60%、97.88%、97.44%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801002848a6cc09c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801002848a6cc09c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4231","BK4139","MGNX","ADC","BK4080"],"gpt_icon":0},{"id":"2555025742","title":"康寧傑瑞：HER2雙抗ADC藥物獲美國FDA孤兒藥資格認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2555025742","media":"生物药大时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555025742?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 00:00","pubTimestamp":1753891244,"startTime":"0","endTime":"0","summary":"7月29日，康宁杰瑞宣布，HER2双特异性抗体偶联药物JSKN003获美国FDA授予孤儿药资格，用于治疗胃癌及胃食管结合部癌。JSKN003是康宁杰瑞利用特有的糖基定点偶联平台自主研发的HER2双抗ADC，将抗体分子KN026重链糖基经过酶催化和点击化学反应获得DAR值约为4的定点修饰抗体偶联物，能够结合肿瘤细胞表面的HER2，通过细胞内吞释放拓扑异构酶Ⅰ抑制剂，进而发挥抗肿瘤作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731010916a6ca0f7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731010916a6ca0f7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFMHRM44.USD","BK4148","BK4080","BK4588","LU0348723411.USD","BK4512","ADC","BK4585","GLW","BK4231"],"gpt_icon":0},{"id":"2555806614","title":"Macrogenics, Inc.盤中異動 股價大跌5.09%報1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555806614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555806614?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 03:59","pubTimestamp":1753819188,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日03时59分，Macrogenics, Inc.股票出现波动，股价大幅下挫5.09%。截至发稿，该股报1.59美元/股，成交量34.5839万股，换手率0.55%，振幅4.79%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073003594897261644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073003594897261644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4231","BK4139","BK4080","ADC"],"gpt_icon":0},{"id":"2555570793","title":"ADC崛起背後的百億美元水漂","url":"https://stock-news.laohu8.com/highlight/detail?id=2555570793","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555570793?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 07:31","pubTimestamp":1753745517,"startTime":"0","endTime":"0","summary":"2024年，全球ADC市场年销售额已突破120亿美元，增长速度远超传统抗体药物。据公开估算，截至2025年中，因临床失败、战略终止或商业前景转向所造成的ADC项目损失已超过134亿美元。Kadcyla是全球首款获批的HER2 ADC，采用了稳定的不可裂解连接子SMCC与微管抑制剂DM1组合，其设计逻辑强调结构稳定、毒性可控。这一对比直观地说明，ADC的核心价值不止于抗体或靶点，而在于杀伤机制与递送机制的一体化化学设计。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729075240a6c69fea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729075240a6c69fea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4516","LU0070302665.USD","LU1066051225.USD","LU0320765489.SGD","LU2361044865.SGD","LU0106261372.USD","LU1941712264.USD","IE00BLSP4239.USD","LU0006306889.USD","PFE","IE00BLSP4452.SGD","IE00BBT3K403.USD","ADC","LU0122379950.USD","LU1989771016.USD","BK4550","LU0211331839.USD","SG9999002232.USD","LU1974910355.USD","LU1929549753.HKD","SG9999014542.SGD","LU1116320737.USD","LU2468319806.SGD","LU0203345920.USD","LU1699723380.USD","LU0965509283.SGD","LU0985320562.USD","SG9999014559.SGD","AZN","BK4007","IE00BN8TJ469.HKD","LU0965509010.AUD","BK4585","IE00B1BXHZ80.USD","BK4588","LU1989772923.USD","SG9999013999.USD","LU1093756168.USD","LU1989772840.SGD","LU2106854487.HKD","LU0058720904.USD","BK4080","LU1585245621.USD","SG9999001440.SGD","LU1291159041.SGD","LU0965509101.SGD","LU1066051498.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4559","IE0009355771.USD","MRK"],"gpt_icon":0},{"id":"2554938557","title":"Macrogenics, Inc.盤中異動 早盤急速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554938557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554938557?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 21:43","pubTimestamp":1753451012,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日21时43分，Macrogenics, Inc.股票出现波动，股价快速跳水5.06%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Phio Pharmaceuticals Corp.、Abpro Holdings, Inc涨幅较大，Phio Pharmaceuticals Corp.、180 Life Sciences Corp.、Nextcure, Inc.较为活跃，换手率分别为595.53%、131.35%、97.00%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Ernexa Therapeutics Inc.、泰坦制药，振幅分别为36.54%、29.52%、27.85%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725214332971e7c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725214332971e7c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4231","BK4080","BK4139","ADC"],"gpt_icon":0},{"id":"2554760238","title":"乳腺癌新輔助治療 阿斯利康(AZN.US)/第一三共HER2 ADC新適應症擬納入優先審評","url":"https://stock-news.laohu8.com/highlight/detail?id=2554760238","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554760238?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 21:13","pubTimestamp":1753449186,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，7月25日，国家药品监督管理局(NMPA)药品审评中心(CDE)官网显示，第一三共与阿斯利康(AZN.US)共同开发的德曲妥珠单抗被纳入拟优先审评行列，用于HER2阳性乳腺癌患者新辅助治疗。医药魔方数据库显示，德曲妥珠单抗已在我国获批了4项适应症，其中两项是乳腺癌相关适应症，分别为：适用于治疗既往接受过一种或多种抗HER2治疗方案的不可切除或转移性HER2阳性乳腺癌成年患者、用于治疗既往在转移性疾病阶段接受过至少一种系统治疗的，或在辅助化疗期间或完成辅助化疗之后6个月内复发的，不可切除或转移性HER2低表达(IHC 1+或IHC 2+/ISH-)成人乳腺癌患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU1829250122.USD","BK4080","LU2456880835.USD","LU2462157665.USD","LU2417539215.USD","BK4007","AZN","LU0320765992.SGD","LU0109394709.USD","BK4568","BK4588","LU0889565916.HKD","BK4231","ADC","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":161,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2025-07-31","symbol":"ADC","amount":0.256,"announcedDate":"2025-07-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-31","defaultRemindTime":1753968600000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-07-31","currency":"USD","dateTimestamp":1753934400000,"payDate":"2025-08-14"},{"market":"US","date":"2025-07-31","symbol":"ADC","fiscalQuarterEnding":"2025/06","expectedEps":1.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"post","actualEps":1.06},{"date":"2025-06-30","symbol":"ADC","amount":0.256,"announcedDate":"2025-06-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-30","defaultRemindTime":1751290200000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-15","payableDate":"2025-06-30","currency":"USD","dateTimestamp":1751256000000,"payDate":"2025-07-15"},{"date":"2025-05-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-13"},{"date":"2025-04-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-30","defaultRemindTime":1746019800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-13","value":0.465,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2016-01-05","value":0.465,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"},{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-10-14","value":0.48,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.381,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.381,"analysts":21,"updateTime":1752206400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2025-08-06","current":44.1564,"percent":0.781759,"low":31.539495,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"high":53.261716,"avg":41.125787,"sd":4.463933,"marketCap":8204612321},"quantilePoints":[{"date":"2020-08-07","current":41.351038,"twenty":30.776927,"median":36.250246,"eighty":43.037844,"marketCap":3707368648},{"date":"2020-08-14","current":40.224323,"twenty":30.922362,"median":36.348523,"eighty":43.037844,"marketCap":3606351900},{"date":"2020-08-21","current":40.308676,"twenty":31.08368,"median":36.544296,"eighty":43.037844,"marketCap":3613914651},{"date":"2020-08-28","current":40.628012,"twenty":31.203975,"median":36.640352,"eighty":43.037844,"marketCap":3642545066},{"date":"2020-09-04","current":40.013441,"twenty":31.296906,"median":36.781594,"eighty":43.037844,"marketCap":3587445022},{"date":"2020-09-11","current":40.079718,"twenty":31.383772,"median":36.974643,"eighty":43.037844,"marketCap":3593387184},{"date":"2020-09-18","current":38.59149,"twenty":31.509762,"median":37.052903,"eighty":43.037844,"marketCap":3459958646},{"date":"2020-09-25","current":37.645532,"twenty":31.534039,"median":37.273263,"eighty":43.037844,"marketCap":3375147794},{"date":"2020-10-02","current":39.29644,"twenty":31.704694,"median":37.362034,"eighty":43.037844,"marketCap":3523161638},{"date":"2020-10-09","current":40.368928,"twenty":31.803276,"median":37.497873,"eighty":43.037844,"marketCap":3619316617},{"date":"2020-10-16","current":39.386818,"twenty":31.867808,"median":37.57347,"eighty":43.037844,"marketCap":3531264585},{"date":"2020-10-23","current":40.224079,"twenty":31.975443,"median":37.612137,"eighty":43.037844,"marketCap":3633239960},{"date":"2020-10-30","current":38.164301,"twenty":31.975443,"median":37.733323,"eighty":43.037844,"marketCap":3447190528},{"date":"2020-11-06","current":38.797606,"twenty":31.975443,"median":37.935059,"eighty":43.037844,"marketCap":3504393786},{"date":"2020-11-13","current":41.26934,"twenty":31.975443,"median":38.046028,"eighty":43.037844,"marketCap":3727653105},{"date":"2020-11-20","current":40.039622,"twenty":31.975443,"median":38.167733,"eighty":43.037844,"marketCap":3616578817},{"date":"2020-11-27","current":40.506914,"twenty":31.975443,"median":38.310136,"eighty":43.037844,"marketCap":3658787046},{"date":"2020-12-04","current":40.580698,"twenty":31.975443,"median":38.471704,"eighty":43.037844,"marketCap":3665451504},{"date":"2020-12-11","current":40.230228,"twenty":31.975443,"median":38.545534,"eighty":43.037844,"marketCap":3633795331},{"date":"2020-12-18","current":39.344831,"twenty":31.975443,"median":38.676992,"eighty":43.037844,"marketCap":3553821844},{"date":"2020-12-24","current":39.762935,"twenty":31.975443,"median":38.782235,"eighty":43.037844,"marketCap":3591587102},{"date":"2020-12-31","current":40.937316,"twenty":31.975443,"median":38.892751,"eighty":43.037844,"marketCap":3697663047},{"date":"2021-01-08","current":45.450661,"twenty":31.975443,"median":39.008592,"eighty":43.047885,"marketCap":4105330986},{"date":"2021-01-15","current":44.653159,"twenty":31.975443,"median":39.245492,"eighty":43.22631,"marketCap":4033296550},{"date":"2021-01-22","current":45.359718,"twenty":31.975443,"median":39.341757,"eighty":43.313411,"marketCap":4097116533},{"date":"2021-01-29","current":44.212433,"twenty":31.975443,"median":39.41667,"eighty":43.4163,"marketCap":3993488046},{"date":"2021-02-05","current":46.262155,"twenty":31.975443,"median":39.41667,"eighty":43.554978,"marketCap":4178629185},{"date":"2021-02-12","current":45.520618,"twenty":31.975443,"median":39.41667,"eighty":43.618647,"marketCap":4111649797},{"date":"2021-02-19","current":43.859591,"twenty":31.975443,"median":39.41667,"eighty":43.642628,"marketCap":4007933303},{"date":"2021-02-26","current":44.718497,"twenty":31.977009,"median":39.430911,"eighty":43.756513,"marketCap":4086420942},{"date":"2021-03-05","current":44.656157,"twenty":31.975443,"median":39.41667,"eighty":43.796506,"marketCap":4080724259},{"date":"2021-03-12","current":46.594043,"twenty":31.975443,"median":39.41667,"eighty":43.856021,"marketCap":4257810284},{"date":"2021-03-19","current":46.240217,"twenty":31.975443,"median":39.41667,"eighty":43.889974,"marketCap":4225477299},{"date":"2021-03-26","current":46.69811,"twenty":31.977009,"median":39.430911,"eighty":43.995818,"marketCap":4267319985},{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-20","current":43.220395,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8269531129},{"date":"2025-06-27","current":41.894687,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8015878004},{"date":"2025-07-03","current":41.30357,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7902777259},{"date":"2025-07-11","current":40.735409,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7794068777},{"date":"2025-07-18","current":41.234702,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7889600473},{"date":"2025-07-25","current":42.319373,"twenty":37.604201,"median":40.725789,"eighty":44.606841,"marketCap":8097134849},{"date":"2025-08-01","current":42.372392,"twenty":37.604201,"median":40.742491,"eighty":44.606841,"marketCap":7873129491},{"date":"2025-08-06","current":44.1564,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"marketCap":8204612321}],"updateTime":1754565599744}}}